Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse.
2010
Abstract Introduction: Interleukin-15 (IL-15) is a proinflammatory cytokine. RANTES is a member of the beta chemokines subfamily with strong chemoattractant activity for T lymphocytes and monocytes. Materials and methods: We measured by enzyme-like immunosorbent assay (ELISA) serum levels of IL-15 and RANTES in 24 patients with MS in relapse, 27 patients with stable MS and 21 healthy subjects. Serum levels of IL-15 and RANTES were also measured before, 5 days and 1 month after onset of treatment with methylprednisolone i.v. Results: IL-15 serum levels were higher in patients with relapse compared with patients in stable stage of the disease and healthy subjects (p=0·001 and p=0·008 respectively). RANTES serum levels were increased in patients with relapse and stable disease as compared to healthy subjects (p=0·01). IL-15 and RANTES levels were not decreased after treatment with corticosteroids. Conclusions: Our findings suggest a possible role of IL-15 and RANTES in MS. Treatment with methylprednisolone i...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
52
References
6
Citations
NaN
KQI